Literature DB >> 23475222

Experimentally-induced Wernicke's encephalopathy modifies crucial rat brain parameters: the importance of Na+, K+ -ATPase and a potentially neuroprotective role for antioxidant supplementation.

Apostolos Zarros1, Charis Liapi, Hussam Al-Humadi, Marianna Almpani, Vasileios Stolakis, Nikolina Skandali, Konstantinos Voumvourakis, Eleni Katsouni, Stylianos Tsakiris.   

Abstract

Wernicke's encephalopathy (WE) is a serious neuropsychiatric syndrome caused by chronic alcoholism and thiamine (T) deficiency. Our aim was to shed more light on the pathophysiology of WE, by introducing a modified in vivo experimental model of WE and by focusing on changes provoked in the total antioxidant status (TAS) and three crucial brain enzyme activities in adult rats. Rats were placed on ethanol (EtOH) consumption (20 % v/v) for a total of 5 weeks. By the end of the third week, rats were fed a T-deficient diet (TDD) and were treated with pyrithiamine (PT; 0.25 mg/kg) for the remaining 2 weeks. Following the induction of WE symptomatology, rats were treated with three consecutive (every 8 h) injections of saline or T (100 mg/kg) and were sacrificed. Brain homogenates were generated and used for spectrophotometrical evaluation of TAS and enzymatic activities. Additionally, in vitro experiments were conducted on brain homogenates or pure enzymes incubated with T or neuromodulatory antioxidants. Pre-exposure to EtOH provided a successful protocol modification that did not affect the expected time of WE symptomatology onset. Administration of T ameliorated this symptomatology. WE provoked oxidative stress that was partially limited by T administration, while T itself also caused oxidative stress to a smaller extent. Brain acetylcholinesterase (AChE) was found inhibited by WE and was further inhibited by T administration. In vitro experiments demonstrated a potential neuroprotective role for L-carnitine (Carn). Brain sodium-potassium adenosine triphosphatase (Na(+),K(+)-ATPase) activity was found increased in WE and was reduced to control levels by in vivo T administration; this increase was also evident in groups exposed to PT or to TDD, but not to EtOH. In vitro experiments demonstrated a potential neuroprotective role for this Na(+),K(+)-ATPase stimulation through T or L-cysteine (Cys) administration. Brain magnesium adenosine triphosphatase (Mg(2+)-ATPase) activity was found decreased by prolonged exposure to EtOH, but was not affected by the experimental induction of WE. Our data suggest that T administration inhibits AChE, which is also found inhibited in WE. Moreover, increased brain Na(+),K(+)-ATPase activity could be a marker of T deficiency in WE, while combined T and antioxidant co-supplementation of Cys and/or Carn could be neuroprotective in terms of restoring the examined crucial brain enzyme activities to control levels.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23475222     DOI: 10.1007/s11011-013-9394-2

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  47 in total

1.  Thiamine and oxidants interact to modify cellular calcium stores.

Authors:  Hsueh-Meei Huang; Huan-Lian Chen; Gary E Gibson
Journal:  Neurochem Res       Date:  2010-08-24       Impact factor: 3.996

2.  Cortical cholinergic abnormalities contribute to the amnesic state induced by pyrithiamine-induced thiamine deficiency in the rat.

Authors:  Steven Anzalone; Ryan P Vetreno; Raddy L Ramos; Lisa M Savage
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

3.  Changes of acetylcholinesterase activity in brain areas and liver of sucrose- and ethanol-fed rats.

Authors:  M J Ruano; M M Sánchez-Martín; J M Alonso; P Hueso
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

4.  Cholinergic parameters and the retrieval of learned and re-learned spatial information: a study using a model of Wernicke-Korsakoff Syndrome.

Authors:  Rita G W Pires; Silvia R C Pereira; Ieda F Oliveira-Silva; Glaura C Franco; Angela M Ribeiro
Journal:  Behav Brain Res       Date:  2005-04-15       Impact factor: 3.332

5.  Effects of L-phenylalanine on acetylcholinesterase and Na(+), K(+)-ATPase activities in adult and aged rat brain.

Authors:  S Tsakiris
Journal:  Mech Ageing Dev       Date:  2001-04-30       Impact factor: 5.432

6.  Effect of L-carnitine administration on the modulated rat brain protein concentration, acetylcholinesterase, Na+K+-ATPase and Mg2+-ATPase activities induced by forced swimming.

Authors:  T Tsakiris; P Angelogianni; C Tesseromatis; S Tsakiris; K H Schulpis
Journal:  Br J Sports Med       Date:  2007-11-05       Impact factor: 13.800

7.  Thiamine deficiency results in downregulation of the GLAST glutamate transporter in cultured astrocytes.

Authors:  Alan S Hazell; Pierre Pannunzio; K V Rama Rao; David V Pow; Andrea Rambaldi
Journal:  Glia       Date:  2003-08       Impact factor: 7.452

8.  Selegiline long-term effects on brain acetylcholinesterase, (Na+,K+)-ATPase activities, antioxidant status and learning performance of aged rats.

Authors:  Haris Carageorgiou; Apostolos Zarros; Stylianos Tsakiris
Journal:  Pharmacol Res       Date:  2003-09       Impact factor: 7.658

9.  Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy.

Authors:  C G Harper; M Giles; R Finlay-Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

10.  Sequence of metabolic, clinical, and histological events in experimental thiamine deficiency.

Authors:  A M Hakim; H M Pappius
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

View more
  1 in total

1.  Exposure to ethanol during neurodevelopment modifies crucial offspring rat brain enzyme activities in a region-specific manner.

Authors:  Vasileios Stolakis; Charis Liapi; Apostolos Zarros; Konstantina Kalopita; Vassilios Memtsas; John Botis; Anastasia Tsagianni; Despoina Kimpizi; Alexios Varatsos; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2015-09-17       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.